The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort ; volume:10 ; number:1 ; day:15 ; month:7 ; year:2020 ; pages:1-10 ; date:12.2020
Scientific reports ; 10, Heft 1 (15.7.2020), 1-10, 12.2020
- Creator
-
Ammari, Maha Al
AlBalwi, Mohammed
Sultana, Khizra
Alabdulkareem, Ibrahim B.
Almuzzaini, Bader
Almakhlafi, Nada S.
Aldrees, Mohammed
Alghamdi, Jahad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-68519-9
- URN
-
urn:nbn:de:101:1-2020090719183462884192
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ammari, Maha Al
- AlBalwi, Mohammed
- Sultana, Khizra
- Alabdulkareem, Ibrahim B.
- Almuzzaini, Bader
- Almakhlafi, Nada S.
- Aldrees, Mohammed
- Alghamdi, Jahad
- SpringerLink (Online service)
Other Objects (12)
Systematic Review of Pharmacogenetic Warfarin Dosing
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Grimmen - 1983 "Warfarin"
Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
Predicting the Quality of Warfarin Therapy: Reframing the Question
Beyond warfarin: The advent of new oral anticoagulants
Beyond warfarin: The advent of new oral anticoagulants
Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
The use of warfarin in veterans with atrial fibrillation
Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
Systematic Review of Pharmacogenetic Warfarin Dosing
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Grimmen - 1983 "Warfarin"
Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
Predicting the Quality of Warfarin Therapy: Reframing the Question
Beyond warfarin: The advent of new oral anticoagulants
Beyond warfarin: The advent of new oral anticoagulants
Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
The use of warfarin in veterans with atrial fibrillation
Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
Systematic Review of Pharmacogenetic Warfarin Dosing
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Grimmen - 1983 "Warfarin"
Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
Predicting the Quality of Warfarin Therapy: Reframing the Question
Beyond warfarin: The advent of new oral anticoagulants
Beyond warfarin: The advent of new oral anticoagulants
Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
The use of warfarin in veterans with atrial fibrillation